| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1379076 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all bearing propargylic ether P1′ groups, was explored. In particular, compound 5h has excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-α production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA.
Graphical abstractCompound 5h with excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-α production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
J.I. Levin, J.M. Chen, L.M. Laakso, M. Du, J. Schmid, W. Xu, T. Cummons, J. Xu, G. Jin, D. Barone, J.S. Skotnicki,